TITLEIST ASSET MANAGEMENT, LTD. Halozyme Therapeutics, Inc. Transaction History

TITLEIST ASSET MANAGEMENT, LTD. portfolio value:

$0
portfolio value

TITLEIST ASSET MANAGEMENT, LTD. quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -4.79K shares -211K $39.54 0
Q2 2022 share Increase 0.00% 4.79K shares 211K $44 4.79K